Loading...
NASDAQ: HOLX
Hologic, Inc.
Healthcare · Medical - Instruments & Supplies
●S&P 500 since 2016
Market Cap
$16.78B
52w High
$75.75
52w Low
$51.90
P/E
31.01
Volume
3.79M
Outstanding Shares
223.24M
Company profile
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally.
CEOStephen MacMillan
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees7,063
IPO dateMar 1, 1990
Valuation
Forward P/E—
EV/EBITDA15.57
Enterprise value$15.94B
Stock splits
Apr 3, 20082:1
Dec 1, 20052:1
Mar 26, 19962:1
Profitability & growth
Revenue growth2.54%
Gross margin52.82%▲10.35%vs FY2024
Operating margin17.49%▼20.45%vs FY2024
ROE11.21%▼27.18%vs FY2024
Analyst consensus
RatingHold
Target price$77.80▲3.53%
18
Buy
23
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.08
$1.05
Q4'25
ActualEst.
$1.13
$1.10
Q1'26
ActualEst.
$1.04
$1.10
Q4FY25
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.02B
$1.03B
Q4'25
ActualEst.
$1.05B
$1.03B
Q1'26
ActualEst.
$1.05B
$1.04B
Q4FY25
Next Est.
—